Literature DB >> 9065185

Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study).

M O Korhonen1, J P Symons, B M Hyde, J P Rowan, W H Wilborn.   

Abstract

OBJECTIVE: The aim of this study was to screen for disorders and to histologically classify endometrial biopsy specimens from 2964 perimenopausal and postmenopausal women who were candidates for hormonal replacement therapy. STUDY
DESIGN: Endometrial biopsy specimens were obtained with a Vabra aspiration curette, processed by standard methods, and stained by hematoxylin and eosin and special methods to reveal subtle features of the endometrium.
RESULTS: Of the endometrial biopsy specimens, 68.7% were atrophic, 23.5% were proliferative, 0.5% were secretory, 0.6% were hyperplastic, 0.07% were adenocarcinoma, and 6.6% were insufficient for classification. Three independent senior microscopists agreed on the classification of each biopsy specimen.
CONCLUSION: The number of patients is the largest ever screened for a single hormone replacement therapy study. The low yield of endometrial cancer indicates that biopsies are unnecessary before hormone replacement therapy is initiated in asymptomatic women.

Entities:  

Mesh:

Year:  1997        PMID: 9065185     DOI: 10.1016/s0002-9378(97)70502-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Incidence of endometrial hyperplasia.

Authors:  Susan D Reed; Katherine M Newton; Walter L Clinton; Meira Epplein; Rochelle Garcia; Kimberly Allison; Lynda F Voigt; Noel S Weiss
Journal:  Am J Obstet Gynecol       Date:  2009-04-23       Impact factor: 8.661

2.  Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.

Authors:  Meira Epplein; Susan D Reed; Lynda F Voigt; Katherine M Newton; Victoria L Holt; Noel S Weiss
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

Review 3.  Hormone replacement therapy and the endometrium.

Authors:  K M Feeley; M Wells
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

4.  Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore.

Authors:  Vivian Wei Wang; Poh Koon Koh; Wai Leng Chow; Jeremy Fung Yen Lim
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

5.  Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.

Authors:  E Sivridis; A Giatromanolaki
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

6.  Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy.

Authors:  Meira Epplein; Susan D Reed; Lynda F Voigt; Katherine M Newton; Victoria L Holt; Noel S Weiss
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

7.  KLF15 negatively regulates estrogen-induced epithelial cell proliferation by inhibition of DNA replication licensing.

Authors:  Sanhita Ray; Jeffrey W Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-26       Impact factor: 11.205

8.  ARID1A Is Essential for Endometrial Function during Early Pregnancy.

Authors:  Tae Hoon Kim; Jung-Yoon Yoo; Zhong Wang; John P Lydon; Shikha Khatri; Shannon M Hawkins; Richard E Leach; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Bon Jeong Ku; Jae-Wook Jeong
Journal:  PLoS Genet       Date:  2015-09-17       Impact factor: 5.917

9.  Endometrial Assessment: When is it Necessary?

Authors:  Juliana Nicoletti Pessoa; Ana Carolina Lopes Freitas; Ronney Antonio Guimaraes; Jonnymar Lima; Helena Lucia Barroso Dos Reis; Antonio Chambo Filho
Journal:  J Clin Med Res       Date:  2013-12-13

Review 10.  Abnormal bleeding during menopause hormone therapy: insights for clinical management.

Authors:  Sebastião Freitas de Medeiros; Márcia Marly Winck Yamamoto; Jacklyne Silva Barbosa
Journal:  Clin Med Insights Womens Health       Date:  2013-01-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.